National, Multicenter, Observational Study Evaluating Prevalence, Virological and Clinical Characteristics of Chronic Hepatitis Delta in Romania and Assess Efficacy of Peg-interferon Alfa-2a Treatment in Patients With Chronic Hepatitis D (CHD)

Trial Profile

National, Multicenter, Observational Study Evaluating Prevalence, Virological and Clinical Characteristics of Chronic Hepatitis Delta in Romania and Assess Efficacy of Peg-interferon Alfa-2a Treatment in Patients With Chronic Hepatitis D (CHD)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2016

At a glance

  • Drugs Peginterferon alfa-2a (Primary)
  • Indications Hepatitis D
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 26 Oct 2016 Status changed from active, no longer recruiting to discontinued.
    • 20 Oct 2014 Planned End Date changed from 1 Mar 2015 to 1 Oct 2014 according to ClinicalTrials.gov record.
    • 14 Oct 2014 Planned End Date changed from 1 Oct 2014 to 1 Mar 2015 according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top